Skip to main content

Table 1 Prediction of putative post-translational modification sites in human STC1.

From: Low-resolution structural studies of human Stanniocalcin-1

Residue

Modification

Buried/Exposed

Residue[51]

Predictor (Score)

Ref.

N62

N-glycosylation

nd

NetGlyc (0.61)

[17, 39, 41, 61]

K83

Sumoylation

e

SUMOplotâ„¢ (0.79)

$

S95

PKC* phosphorylation

b

NetPhos (0.844)/NetPhosK (0.630)

[50]

S115

PKC* phosphorylation

nd

NetPhos (0.788)/NetPhosK (0.722)

[50]

 

PKA* phosphorylation

nd

NetPhos (0.788)/NetPhosK (0.841)

[50]

 

RSK* phosphorylation

nd

NetPhos (0.788)/NetPhosK (0.601)

nd

Y159

INSR* phosphorylation

nd

NetPhos (0.929)/NetPhosK (0.539)

nd

S176

PKC* phosphorylation

e

NetPhos (0.938)/NetPhosK (0.630)

[50]

T177

PKC* phosphorylation

nd

NetPhos (0.983)/NetPhosK (0.640)

[50]

S181

PKA* phosphorylation

nd

NetPhos (0.993)/NetPhosK (0.647)

[50]

T205

PKC* phosphorylation

nd

NetPhos (0.606)/NetPhosK (0.815)

[50]

 

Cdc2* phosphorylation

nd

NetPhos (0.606)/NetPhosK (0.509)

[50]

T216

PKG* phosphorylation

e

NetPhos (0.817)/NetPhosK (0.600)

[50]

S235

GSK3* phosphorylation

nd

NetPhos (0.986)/NetPhosK (0.508)

[50]

 

Cdk5* phosphorylation

nd

NetPhos (0.986)/NetPhosK (0.551)

[50]

S237

PKC* phosphorylation

nd

NetPhos (0.531)/NetPhosK (0.647)

[50]

T242

PKG* phosphorylation

nd

NetPhos (0.523)/NetPhosK (0.693)

[50]

  1. High score predictions of glycosylation, sumoylation and phosphorylation on STC1 sequence are presented. Predicted modifications within the pro-peptide region were excluded. Putative phosphorylated residues shown here are only those that were both predicted with the highest scores by the NetPhos server and additionally were predicted by NetPhosK, which suggests a specific kinase for the same site. References are related to additional experimental support for the predicted modification, if available. * indicate kinase as predicted by NetPhosK [protein kinase A C or G (PKA; PKC and PKG); 90-kDa Ribosomal S6 Kinase (pp90RSK or RSK); Insulin receptor (INSR); cell division cycle 2 (cdc2 or p34 protein kinase); ciclin dependent kinase 5 (cdk5); Glycogen synthase kinase 3 (GSK3)]; e = exposed residue, b = buried residue, nd = not determined; $ = unpublished data.